“…The FLASH effect, as noted above, is defined by the preservation of normal tissues simultaneous with antitumor efficacy equivalent to that of CONV RT at the same dose level. 1,12,13,15,22,23,[35][36][37][38][39] To date, the FLASH effect has been characterized in several in vivo models, primarily wild-type mice, and in several organ systems, as summarized in Table 2. These organs include either the so-called acute-responding organs (gut, hematopoietic system) 36,40 as well as late-responding organs (brain, lung, skin), 1,12,13,15,22,23,35,37,38,41,42 thereby suggesting that FLASH RT modifies a common initial event that can control the development of both acute and delayed toxicity.…”